Case Study: School Premises Liability, C5-C6 Disc Herniation, and Pharmacy Lien When Blue Cross Denies Compound Medications

James Wong — Founder & Pharmacist, LienScripts | February 19, 2026 | 8 min read

A 42-year-old nurse slips on a wet school hallway floor during pickup, sustaining a C5-C6 disc herniation with radiculopathy and a left shoulder contusion. With a 6-month government claim deadline, health insurance denying compounded topicals and out-of-network specialists, and the defense poised to argue pre-existing degenerative changes, a pharmacy lien and clean MERIT become essential to the case.

Case Background

Fictional Disclaimer: The patient, injuries, insurance coverage details, and case timeline described below are composite and fictional. They are intended to illustrate how pharmacy lien programs function in government entity premises liability cases where health insurance coverage is incomplete. No real patient data was used.

Sandra, a 42-year-old emergency department nurse, arrived at her daughter's school at 3:15 PM for standard afternoon pickup. The hallway outside the main office — recently mopped — had no wet floor signage and was still visibly damp. She slipped on the way to the front desk, fell forward, and caught herself partially with her left arm while twisting her neck and upper back.

In the emergency department that evening (not her own hospital — she was treated at a facility away from where she worked, to avoid awkwardness), the attending ordered cervical X-rays and a shoulder series. X-rays were unremarkable. An MRI ordered four days later showed a C5-C6 disc herniation with left-sided foraminal narrowing and mild cord contact — consistent with her radicular symptoms into the left arm and hand. The shoulder showed soft tissue contusion and a partial thickness rotator cuff irritation, no complete tear.

Sandra had Blue Cross PPO coverage through her hospital employer. This would ordinarily make her well-positioned for treatment. But two factors complicated the insurance picture:

First, the school district is a government entity — a California public school district. Claims against government entities in California require filing a government tort claim within six months of the injury. Miss that deadline and the case is over, regardless of how clear the liability is. Her attorney filed the claim at week three.

Second, Blue Cross denied several treatment components as either out-of-network (her physiatrist was not in-network) or categorically non-covered (compounded topical medications). The pharmacy lien stepped in to cover exactly those gaps.

Government Entity Cases: The Deadline Changes Everything

The six-month government tort claim deadline (California Government Code § 911.2) is non-negotiable in most circumstances. It runs from the date of the injury. If no claim is filed within that period, the plaintiff is barred from suit. There are narrow exceptions — late claim applications, discovery rules for latent injuries — but they are fact-specific and often unsuccessful.

[!KEY] In California government entity premises liability cases, the six-month claim deadline under Government Code § 911.2 controls. Attorneys accepting these cases must treat the claim filing deadline as a hard stop. The pharmacy lien should be activated at intake alongside the government claim — not after.

Sandra's attorney filed within three weeks. The school district's risk management office acknowledged receipt and began its investigation. They quickly took the position that the hallway mopping was completed 45 minutes prior to the incident, that the floor was dry, and that no notice existed of a wet condition. That dispute — over the timing of the mopping and the absence of signage — would be the factual battleground.

Meanwhile, Sandra needed treatment. She had neck pain with left arm radiculopathy, shoulder pain, and headaches beginning in week two that her physiatrist attributed to cervicogenic origin. All of it needed management.

Pharmacy Lien Coverage: What Blue Cross Would and Would Not Pay

Sandra's Blue Cross PPO covered most of her care — but specifically denied or declined:

1. Compounded cervical topical (ketamine/baclofen/gabapentin cream, prescribed by her out-of-network physiatrist) — compounded medications are categorically excluded from most commercial health insurance formularies
2. Diclofenac sodium gel (Voltaren) — her plan required prior authorization that was not obtained in time; she needed relief before the PA process completed
3. Gabapentin, initial fills — her PCP wrote the first script before the physiatrist visit; the plan required specialist authorization for gabapentin in cervical radiculopathy

All three came through the pharmacy lien from the first month onward. Once the PA was approved for gabapentin, those fills transferred to her insurance. The compounded cervical topical remained on lien throughout.

The full medication arc over eleven months included:

• Gabapentin 300 mg TID, titrated up to 600 mg TID at month two as radiculopathy worsened before beginning to improve
• Cyclobenzaprine 5 mg TID for cervical muscle spasm (short course, two months)
• Diclofenac sodium gel (topical, applied to the cervical paraspinal region and left shoulder)
• Compounded cervical topical (ketamine/baclofen/gabapentin base, applied to the posterior cervical and upper trapezius region twice daily)

[!KEY] Commercial health insurers routinely deny compounded topicals as "not medically necessary" or "non-covered" as a blanket policy — not based on clinical review of the individual patient. A pharmacy lien covers these medications without requiring formulary approval. For cervical radiculopathy patients where topical delivery reduces systemic side effects, the clinical rationale is well-supported.

The Pre-Existing Degenerative Change Defense

Sandra's MRI at C5-C6 showed the herniation plus mild degenerative disc changes at multiple levels — the kind of finding that is nearly universal in adults over 40 and has no clinical significance unless symptomatic. The defense immediately latched onto the degenerative changes as evidence of a pre-existing symptomatic condition.

Their expert, a spine radiologist, opined that the disc herniation was "chronic" in appearance. Her treating neurosurgeon disagreed, noting that the herniation was acute in several characteristics and that acute herniations frequently occur on top of mild chronic degenerative backgrounds — neither feature cancels the other.

The medical records were clear: Sandra had no prior cervical treatment. She had no prior chiropractic, no prior imaging, no prior neurology referrals. She had not filed for any disability related to her neck or upper extremity. As a working emergency department nurse — a physically demanding job — she had been functioning without restriction before the fall.

[!SOURCE] Degenerative disc changes are common radiographic findings in asymptomatic adults over 40 and do not independently indicate prior symptomatic cervical disc disease. See: Brinjikji W et al., "Systematic literature review of imaging features of spinal degeneration in asymptomatic populations," American Journal of Neuroradiology, 2015 — finding that disc degeneration is present in 37% of 20-year-olds and 96% of 80-year-olds with no symptoms.

The MERIT in this case was a decisive document. Sandra's medication history showed no prior fills for gabapentin, cyclobenzaprine, topical pain preparations, or any cervical-adjacent pain medications before the fall date. A nurse managing a symptomatic cervical disc herniation at work would not have gone untreated. The MERIT showed exactly what the medical records showed: no prior treatment, no prior medications, clean presentation before October.

The Case Resolution

The school district's initial defense posture — that the floor was dry — was undermined when the plaintiff's investigator found a school custodial log showing the hallway had been mopped at 2:45 PM. The district's own records indicated mopping, 30 minutes before Sandra arrived. The wet floor signage kit was photographed by the investigator — in the supply closet, unused.

The district's risk management team shifted posture at mediation, moving from liability denial to damages negotiation. Sandra's case resolved at month eleven through a mediated settlement. Her pharmacy lien was negotiated as part of the global resolution process — the standard workflow regardless of whether the defendant is a private party or a government entity.

The compounded cervical topical remained on lien through final settlement. Without the lien, Sandra would either have paid for it out of pocket throughout her treatment or gone without — neither acceptable for a case that required consistent documented treatment to counter the pre-existing condition defense.

Key Takeaways for Attorneys

Government entity premises liability cases move on tight timelines. The pharmacy lien should be activated at the same time as the government claim — not after the investigation period closes. Waiting for liability clarity wastes months of documented treatment that strengthens the damages case.

When health insurance covers most medications but denies compounded preparations and some specialist-written prescriptions, the pharmacy lien fills those specific gaps. It is not an all-or-nothing instrument. Properly scoped, it covers exactly what the health insurer refuses to pay, without triggering subrogation issues on the covered medications.

In degenerative change defense cases, the MERIT is not just useful — it is the clean evidentiary baseline that demonstrates the patient was functioning without pharmaceutical pain management before the injury date.

Related Resources

• What Is a Pharmacy Lien?
• Compound Medications in Personal Injury Cases
• Gabapentin vs. Pregabalin in Personal Injury
• Health Insurance Subrogation vs. Pharmacy Lien
• Pharmacy Lien Support for Chiropractors and Personal Injury